avalaible - European Test Symposium
This strategy seeks to tailor therapy dynamically to tumor behavior, potentially reducing toxicity and managing resistance more effectively.
original - RetzmotoA quoi fait-on référence lorsqu'on parle d'innovation en. Chine aujourd'hui ? Ce thème renvoie de manière plus globale à celui de l'innovation par les pays. Conditional Success of Adaptive Therapy - bioRxiv7.In late 2005, the TD-SCDMA was approved by China's 3G Partnership Project as one of the ... You, Wuyang, and Qin Tao. 2003. Informatization and the Future China ... Identification et caractérisation d'une isoforme mitochondriale du ...Global LNG's growth trajectory continued in 2024, marked by a further 2.4% increase in LNG trade, the addition of 6.5 MTPA.
Autres Cours:
